To support researchers in developing countries, BioMed Central operates a waiver scheme that enables authors to publish their research in a BioMed Central journal without incurring the usual article-processing charge.

BioMed Central provides an automatic waiver to authors based in any country, which was classified by the World Bank as Low-income economies or Lower-middle-income economies as of December 2011, and which has a 2010 gross domestic product of less than 200 billion US dollars (reference - World Bank 1st December 2011).

To submit your next research article to a BioMed Central journal, simply visit the BioMed Central website and request the appropriate waiver option during the submission process.

If your company would like to support open access research within developing countries in recognition of the global importance of scientific access to medical journals, please contact Bev Acreman, Commercial Director.